Stepwise frontal affinity chromatography model for drug and protein interaction

Area of Science:

• Biochemistry
• Analytical Chemistry
• Pharmacology

Background:

• Frontal affinity chromatography (FAC) is a powerful technique for studying drug-protein interactions.
• Stepwise frontal analysis (SFA) builds upon FAC, offering enhanced analytical capabilities.
• Understanding drug-protein binding is crucial for drug development and efficacy.

Purpose of the Study:

• To investigate the application of the Lineweaver-Burk plot within the stepwise frontal analysis model.
• To validate the accuracy of SFA by comparing its results with traditional frontal analysis.
• To determine equilibrium dissociation constants (Kd) for model drugs binding to human serum albumin (HSA) and alpha-1-acid glycoprotein (AGP).

Main Methods:

• Utilized commercial HSA and AGP columns for affinity chromatography.
• Employed frontal analysis and stepwise frontal analysis with model drugs (warfarin, digitoxin, verapamil, tamsulosin).
• Applied the Lineweaver-Burk plot to weighted average time data obtained from SFA.

Main Results:

• Demonstrated a strong correlation (r² = 0.9946-0.9998) between time data from frontal analysis and SFA.
• Successfully determined equilibrium dissociation constants (Kd) for model drugs, consistent with literature values.
• Confirmed the feasibility and reliability of converting time data in the SFA model.

Conclusions:

• The Lineweaver-Burk plot is a viable method for stepwise frontal analysis of drug-protein interactions.
• SFA provides accurate and reliable data for characterizing drug-protein binding affinities.
• This approach offers a robust tool for studying the complex interactions between drugs and plasma proteins.